E-LIB Suche - Ergebnisse für: Cohen, Margo P.

1

Clinical, pathophysiological and structure/function consequ..:

Cohen, Margo P.
Biochimica et Biophysica Acta (BBA) - General Subjects. 1830 (2013) 12 - p. 5480-5485 , 2013

Link: https://doi.org/10.1016/..

2

Inhibiting Amadori-modified albumin formation improves biom..:

Cohen, Margo P. ; Shearman, Clyde W.
Physiological Reports. 1 (2013) 4 - p. , 2013

Link: https://doi.org/10.1002/..

3

Effects of nonenzymatic glycation and fatty acids on functi..:

Lautenslager, Gregory T. ; Shearman, Clyde W. ; Hud, Elizabeth.
Metabolism. 60 (2011) 12 - p. 1683-1691 , 2011

Link: https://doi.org/10.1016/..

4

Inhibiting low-density lipoprotein glycation ameliorates in..:

Cohen, Margo P. ; Shea, Elizabeth A. ; Wu, Van-Yu
Metabolism. 59 (2010) 5 - p. 658-663 , 2010

Link: https://doi.org/10.1016/..

5

Reduction of Aβ42 in brains of transgenic APPswe mice by 2‐..:

Cohen, Margo P ; Shearman, Clyde W
Clinical and Experimental Pharmacology and Physiology. 36 (2009) 11 - p. 1099-1103 , 2009

Link: https://doi.org/10.1111/..

6

Amadori-modified glycated serum proteins and accelerated at..:

Cohen, Margo P. ; Ziyadeh, Fuad N. ; Chen, Sheldon
Journal of Laboratory and Clinical Medicine. 147 (2006) 5 - p. 211-219 , 2006

Link: https://doi.org/10.1016/..

7

Increased Plasma Glycated Low-Density Lipoprotein Concentra..:

Cohen, Margo P. ; Jin, Yulin ; Lautenslager, Gregory T.
Diabetes Technology & Therapeutics. 6 (2004) 3 - p. 348-356 , 2004

Link: https://doi.org/10.1089/..

8

Glycated albumin increases oxidative stress, activates NF-κ..:

Cohen, Margo P. ; Shea, Elizabeth ; Chen, Sheldon.
Journal of Laboratory and Clinical Medicine. 141 (2003) 4 - p. 242-249 , 2003

Link: https://doi.org/10.1067/..

9

Intervention strategies to prevent pathogenetic effects of ..:

Cohen, Margo P
Archives of Biochemistry and Biophysics. 419 (2003) 1 - p. 25-30 , 2003

Link: https://doi.org/10.1016/..

10

Normalizing glycated albumin reduces increased urinary coll..:

Cohen, Margo P. ; Hud, Elizabeth ; Shea, Elizabeth.
Metabolism. 51 (2002) 7 - p. 901-905 , 2002

Link: https://doi.org/10.1053/..

11

Identification of Calnexin as a Binding Protein for Amadori..:

Wu, Van-Yu ; Shearman, Clyde W. ; Cohen, Margo P.
Biochemical and Biophysical Research Communications. 284 (2001) 3 - p. 602-606 , 2001

Link: https://doi.org/10.1006/..

12

ERK Mediates Effects of Glycated Albumin in Mesangial Cells:

Cohen, Margo P. ; Shea, Elizabeth ; Shearman, Clyde W.
Biochemical and Biophysical Research Communications. 283 (2001) 3 - p. 641-643 , 2001

Link: https://doi.org/10.1006/..

13

Increased urinary type IV collagen marks the development of..:

Cohen, Margo P. ; Lautenslager, Gregory T. ; Shearman, Clyde W.
Metabolism. 50 (2001) 12 - p. 1435-1440 , 2001

Link: https://doi.org/10.1053/..

14

Measuring Glycated Proteins: Clinical and Methodological As..:

Cohen, Margo P. ; Clements, Rex S.
Diabetes Technology & Therapeutics. 1 (1999) 1 - p. 57-70 , 1999

Link: https://doi.org/10.1089/..

15

Anti-Glycated Albumin Therapy Ameliorates Early Retinal Mic..:

Clements Jr., Rex S ; Robison Jr., W.Gerald ; Cohen, Margo P
Journal of Diabetes and its Complications. 12 (1998) 1 - p. 28-33 , 1998

Link: https://doi.org/10.1016/..